We are live on
!
Find out more
CP
Castleview Partners Portfolio holdings
AUM
$228M
1-Year Est. Return
13.32%
This Fund
S&P 500
This Quarter
Est. Return
+8.05%
1 Year Est. Return
+13.32%
3 Year Est. Return
+61.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$32.4M
(+17%)
Cap. Flow
+$22.9M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
251
New
51
Increased
110
Reduced
51
Closed
28
Avg Time Held
9.6
quarters
Top 10 Avg Time Held
5.6
quarters
Top 20 Avg Time Held
5.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomura Tax-Free USA Short Term ETF
STAX
|
+$5.68M |
| 2 |
Stryker
SYK
|
+$2.63M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$1.94M |
| 4 |
Tesla
TSLA
|
+$1.66M |
| 5 |
Angel Oak UltraShort Income ETF
UYLD
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity High Dividend ETF
FDVV
|
+$2.98M |
| 2 |
Fidelity Enhanced Large Cap Growth ETF
FELG
|
+$2M |
| 3 |
Vanguard 0-3 Month Treasury Bill ETF
VBIL
|
+$1.74M |
| 4 |
abrdn Physical Silver Shares ETF
SIVR
|
+$1.63M |
| 5 |
VanEck Inflation Allocation ETF
RAAX
|
+$885K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.1% |
| 2 | Healthcare | 9.45% |
| 3 | Technology | 8.15% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Financials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Regan Floating Rate MBS ETF
MBSF
$242M
| $25.4M | 11.16% |
988,999
+1,683
| +0.2% | +$43.2K |
2024 Q1
9 quarters
|
|
2
Regan Fixed Rate MBS ETF
MBSX
$18.3M
| $9.02M | 3.96% |
330,184
+30,467
| +10% | +$815K |
2025 Q2
4 quarters
|
|
|
3
Tesla
TSLA
$1.48T
| $7.31M | 3.21% |
17,372
+4,185
| +32% | +$1.66M |
2021 Q2
20 quarters
|
|
4
Apple
AAPL
$4.98T
| $6.94M | 3.05% |
23,991
-1,455
| -6% | -$416K |
2023 Q1
13 quarters
|
|
|
5
Nomura Tax-Free USA Short Term ETF
STAX
$12.4M
| $5.68M | 2.5% |
+223,409
| New | +$5.68M |
2026 Q2
0 quarters
|
|
6
Home Depot
HD
$293B
| $4.9M | 2.15% |
13,894
+2,821
| +25% | +$918K |
2018 Q1
33 quarters
|
|
7
ConocoPhillips
COP
$169B
| $4.9M | 2.15% |
47,126
-2,317
| -5% | -$275K |
2024 Q4
6 quarters
|
|
8
Leuthold Select Industries ETF
LST
$205M
| $4.88M | 2.15% |
104,523
-14,885
| -12% | -$667K |
2025 Q1
5 quarters
|
|
9
Bristol-Myers Squibb
BMY
$116B
| $4.81M | 2.12% |
83,526
+9,538
| +13% | +$548K |
2018 Q1
33 quarters
|
|
10
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $4.74M | 2.08% |
6,348
-23
| -0.4% | -$16.7K |
2018 Q1
33 quarters
|
|
11
KKR & Co
KKR
$78.2B
| $4.4M | 1.93% |
47,966
+11,205
| +30% | +$1.09M |
2025 Q4
2 quarters
|
|
12
Amgen
AMGN
$223B
| $3.82M | 1.68% |
10,552
+2,692
| +34% | +$922K |
2023 Q1
13 quarters
|
|
13
PMV Adaptive Risk Parity ETF
ARP
$75.1M
| $3.81M | 1.67% |
117,314
-847
| -0.7% | -$27.7K |
2025 Q1
5 quarters
|
|
14
UnitedHealth
UNH
$339B
| $3.69M | 1.62% |
8,888
-1,083
| -11% | -$401K |
2021 Q2
20 quarters
|
|
15
ProShares Ultra QQQ
QLD
$15.2B
| $2.89M | 1.27% |
29,895
+8,178
| +38% | +$703K |
2022 Q2
16 quarters
|
|
|
16
Stryker
SYK
$108B
| $2.62M | 1.15% |
+8,332
| New | +$2.63M |
2026 Q2
0 quarters
|
|
17
Vanguard S&P 500 ETF
VOO
$1.05T
| $2.49M | 1.09% |
3,622
+52
| +1% | +$34.7K |
2018 Q1
33 quarters
|
|
18
FS Credit Opportunities Corp
FSCO
$999M
| $2.43M | 1.07% |
487,964
+56,109
| +13% | +$282K |
2024 Q2
8 quarters
|
|
|
19
Angel Oak UltraShort Income ETF
UYLD
$1.37B
| $2.32M | 1.02% |
45,487
+26,935
| +145% | +$1.38M |
2026 Q1
1 quarter
|
|
20
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $2.23M | 0.98% |
44,186
-2,300
| -5% | -$116K |
2021 Q2
20 quarters
|
|
|
21
VanEck Inflation Allocation ETF
RAAX
$1.4B
| $2.23M | 0.98% |
56,092
-21,478
| -28% | -$885K |
2025 Q4
2 quarters
|
|
|
22
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
| $2.01M | 0.88% |
+12,233
| New | +$1.94M |
2026 Q2
0 quarters
|
|
23
VanEck Merk Gold Trust
OUNZ
$2.69B
| $1.9M | 0.83% |
49,205
+9,887
| +25% | +$429K |
2022 Q1
17 quarters
|
|
24
NVIDIA
NVDA
$5.52T
| $1.83M | 0.8% |
9,147
-750
| -8% | -$154K |
2021 Q2
20 quarters
|
|
25
Elevance Health
ELV
$92.2B
| $1.82M | 0.8% |
4,703
-353
| -7% | -$131K |
2024 Q4
6 quarters
|
|
Similar funds
SPFA
BIA
MA
DCC
WCM
IAAG
ACM
TI
Castleview Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Castleview Partners held 251 positions worth $228M, up 17% from $195M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Castleview Partners deployed $22.9M of net new capital in Q2 2026, opening 51 new positions and adding to 110 existing holdings. Its largest new stake was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Fidelity Enhanced Large Cap Growth ETF, an estimated $2M trimmed.
- Castleview Partners's largest Q2 2026 buy was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.
- Castleview Partners added most to Tesla in Q2 2026, an estimated $1.66M increase.
- Castleview Partners's biggest Q2 2026 reduction was Fidelity Enhanced Large Cap Growth ETF, cutting an estimated $2M.
- Castleview Partners fully exited Fidelity High Dividend ETF in Q2 2026, selling an estimated $2.98M.
- Castleview Partners's ten largest holdings make up 35% of its $228M portfolio in Q2 2026.
- Castleview Partners opened 51 new positions and closed 28 in Q2 2026.
- Castleview Partners's portfolio value rose 17% quarter-over-quarter to $228M.
Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.